BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 29790176)

  • 1. Tau filaments in neurodegenerative diseases.
    Goedert M
    FEBS Lett; 2018 Jul; 592(14):2383-2391. PubMed ID: 29790176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of filaments from Pick's disease reveal a novel tau protein fold.
    Falcon B; Zhang W; Murzin AG; Murshudov G; Garringer HJ; Vidal R; Crowther RA; Ghetti B; Scheres SHW; Goedert M
    Nature; 2018 Sep; 561(7721):137-140. PubMed ID: 30158706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered Assembly of Tau Protein and Neurodegeneration.
    Goedert M; Spillantini MG
    Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal tau-containing filaments in neurodegenerative diseases.
    Crowther RA; Goedert M
    J Struct Biol; 2000 Jun; 130(2-3):271-9. PubMed ID: 10940231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and pathological heterogeneity of primary tauopathies.
    Chung DC; Roemer S; Petrucelli L; Dickson DW
    Mol Neurodegener; 2021 Aug; 16(1):57. PubMed ID: 34425874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy.
    Lövestam S; Koh FA; van Knippenberg B; Kotecha A; Murzin AG; Goedert M; Scheres SHW
    Elife; 2022 Mar; 11():. PubMed ID: 35244536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases.
    Goedert M; Spillantini MG; Serpell LC; Berriman J; Smith MJ; Jakes R; Crowther RA
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):213-27. PubMed ID: 11260802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.
    Siddiqua A; Margittai M
    J Biol Chem; 2010 Nov; 285(48):37920-6. PubMed ID: 20921227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the tauopathies.
    Goedert M; Spillantini MG
    J Mol Neurosci; 2011 Nov; 45(3):425-31. PubMed ID: 21785996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propagation of Tau aggregates.
    Goedert M; Spillantini MG
    Mol Brain; 2017 May; 10(1):18. PubMed ID: 28558799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Oligomers.
    Maeda S; Takashima A
    Adv Exp Med Biol; 2019; 1184():373-380. PubMed ID: 32096050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.
    Goedert M; Spillantini MG
    Biochim Biophys Acta; 2000 Jul; 1502(1):110-21. PubMed ID: 10899436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structures of tau filaments.
    Scheres SH; Zhang W; Falcon B; Goedert M
    Curr Opin Struct Biol; 2020 Oct; 64():17-25. PubMed ID: 32603876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological tau phenotypes. The weight of mutations, polymorphisms, and differential neuronal vulnerabilities.
    Mailliot C; Bussière T; Hamdane M; Sergeant N; Caillet ML; Delacourte A; Buée L
    Ann N Y Acad Sci; 2000; 920():107-14. PubMed ID: 11193138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau gene mutations: dissecting the pathogenesis of FTDP-17.
    Ingram EM; Spillantini MG
    Trends Mol Med; 2002 Dec; 8(12):555-62. PubMed ID: 12470988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau and neurodegeneration.
    Goedert M; Crowther RA; Scheres SHW; Spillantini MG
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):95-102. PubMed ID: 38073060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits.
    Murrell JR; Spillantini MG; Zolo P; Guazzelli M; Smith MJ; Hasegawa M; Redi F; Crowther RA; Pietrini P; Ghetti B; Goedert M
    J Neuropathol Exp Neurol; 1999 Dec; 58(12):1207-26. PubMed ID: 10604746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.
    Buée L; Bussière T; Buée-Scherrer V; Delacourte A; Hof PR
    Brain Res Brain Res Rev; 2000 Aug; 33(1):95-130. PubMed ID: 10967355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.